Company: HCWB
Filing Date: 2025-02-21
Form Type: DEF 14A
Source: 0001193125-25-032115
Chunk: 62

Company: HCW Biologics Inc.
Filing Date: 2025-02-21
Form: DEF 14A
Chunk 62
---
 provided notice to the Company that it believes it has received information that constitutes material, non-public information, and the Company
shall

- A-16 -

have had at least twenty-four (24) hours to publicly disclose such material, non-public information prior to any such disclosure by the Investor, and
the Company shall have failed to publicly disclose such material, non-public information within such time period. The Investor shall not have any liability to the Company, any Subsidiary, or any of their
respective directors, officers, employees, stockholders, affiliates, or agents, for any such disclosure. The Company understands and confirms that the Investor shall be relying on the foregoing covenants in effecting transactions in securities of
the Company.

Section 6.6 . The Company shall maintain records showing the Available Amount at any given
time and the date, Investment Amount and Put Shares for each Put, contained in the applicable Put Notice.

Section 6.7 . The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to
the issuance and delivery of any shares of Common Stock to the Investor made under this Agreement.

Section 6.8 . The Company will use the net proceeds from the offering of Put Shares hereunder for the purposes described in the Registration Statement.

Section 6.9 . The Company shall not enter into, announce or recommend to its stockholders any agreement,
plan, arrangement or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the Company to perform its obligations under the Transaction Documents, including, without
limitation, the obligation of the Company to deliver the Put Shares and the Commitment Shares to the Investor in accordance with the terms of the Transaction Documents.

Section 6.10 . In any case subject to the terms of the Registration Rights Agreement, from and after the
Execution Date, neither the Company, nor or any of its Subsidiaries or Affiliates will, and the Company shall use its reasonable efforts to ensure that no Person acting on their behalf will, directly or indirectly, make any offers or sales of any
security or solicit any offers to buy any security, under circumstances that would require registration of the offer and sale of any of the Securities under the Securities Act.

Section 6.11 . On the Execution Date, the Company shall deliver to the Investor executed copies of all
of the Transaction Documents.

Section 6.12 . Unless waived by the Investor, notwithstanding any